Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Lenalidomide is an immunomodulatory drug with therapeutic activity in chronic lymphocytic leukemia (CLL). However, it has pleiotropic effects, and the mechanism of action responsible for its therapeutic activity has not been well defined yet. Herein, we show that lenalidomide treatment does not have...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Gonzalez-Rodriguez, Ana Pilar, Fernandez-Guizan, Azahara, Payer, Angel R., López-Soto, Alejandro, Gonzalez, Segundo
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi Publishing Corporation 2014
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4182694/
https://ncbi.nlm.nih.gov/pubmed/25313353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/265840
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker